555 related articles for article (PubMed ID: 28416734)
1. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
[TBL] [Abstract][Full Text] [Related]
2. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F
Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
Du N; Feng J; Hu LJ; Sun X; Sun HB; Zhao Y; Yang YP; Ren H
Oncol Rep; 2012 Jun; 27(6):1893-903. PubMed ID: 22426690
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin receptor signaling and prostate tumor growth in mice.
Scott-Emuakpor J; Allot E; Johnson SA; Howard LE; Macias E; Freedland SJ; Gurley SB
J Exp Ther Oncol; 2017 Sep; 11(2):107-115. PubMed ID: 28976133
[TBL] [Abstract][Full Text] [Related]
5. Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.
Saber S; Mahmoud AAA; Goda R; Helal NS; El-Ahwany E; Abdelghany RH
Toxicol Lett; 2018 Oct; 295():32-40. PubMed ID: 29859236
[TBL] [Abstract][Full Text] [Related]
6. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Maglione JE; McGoldrick ET; Liu S; Wurz GT; DeGregorio MW; Borowsky AD; MacLeod CL; Cardiff RD; Gregg JP
Breast Cancer Res; 2005; 7(6):R881-9. PubMed ID: 16280035
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
Anandanadesan R; Gong Q; Chipitsyna G; Witkiewicz A; Yeo CJ; Arafat HA
J Gastrointest Surg; 2008 Jan; 12(1):57-66. PubMed ID: 18026817
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
Bose SK; Gibson W; Giri S; Nath N; Donald CD
Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma.
Park YA; Choi CH; Do IG; Song SY; Lee JK; Cho YJ; Choi JJ; Jeon HK; Ryu JY; Lee YY; Kim TJ; Bae DS; Lee JW; Kim BG
Gynecol Oncol; 2014 Oct; 135(1):108-17. PubMed ID: 25014541
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
14. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Inflammation after Ischemia-Reperfusion of the Kidney: Role of the Sympathetic Nervous System and the Renin-Angiotensin System.
Panico K; Abrahão MV; Trentin-Sonoda M; Muzi-Filho H; Vieyra A; Carneiro-Ramos MS
Cell Physiol Biochem; 2019; 53(4):587-605. PubMed ID: 31535830
[TBL] [Abstract][Full Text] [Related]
16. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
Ager EI; Wen SW; Chan J; Chong WW; Neo JH; Christophi C
BMC Cancer; 2011 Jun; 11():274. PubMed ID: 21703011
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of modeling effects of two different 7, 12-dimethylbenz[a] anthracene induced breast cancer models in tree shrew].
Mao AY; Chen MJ; Yang C; Ou C; Ye XQ; Qin QH; Mo M; Wei CY
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):346-350. PubMed ID: 31137167
[No Abstract] [Full Text] [Related]
18. Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer.
Chen X; Meng Q; Zhao Y; Liu M; Li D; Yang Y; Sun L; Sui G; Cai L; Dong X
Cancer Lett; 2013 Jan; 328(2):318-24. PubMed ID: 23092556
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis.
Oh E; Kim JY; Cho Y; An H; Lee N; Jo H; Ban C; Seo JH
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1071-81. PubMed ID: 26975580
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of central angiotensin II type 1 receptor associated neurocircuits in carbon dioxide associated fear.
Winter A; Ahlbrand R; Sah R
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():378-386. PubMed ID: 30776402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
